Clinical Trials · NCT04983095
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Karin Soderkvist
- Enrollment
- 118
- Start date
- Oct 2021
- Locations
- 7 sites, Sweden
- Primary endpoint
- Failure free survival